DK2078038T3 - Rekonstituerede surfaktanter med forbedrede egenskaber - Google Patents

Rekonstituerede surfaktanter med forbedrede egenskaber

Info

Publication number
DK2078038T3
DK2078038T3 DK07825212.9T DK07825212T DK2078038T3 DK 2078038 T3 DK2078038 T3 DK 2078038T3 DK 07825212 T DK07825212 T DK 07825212T DK 2078038 T3 DK2078038 T3 DK 2078038T3
Authority
DK
Denmark
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
surfactants
properties
Prior art date
Application number
DK07825212.9T
Other languages
Danish (da)
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2078038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK2078038T3 publication Critical patent/DK2078038T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DK07825212.9T 2006-10-13 2007-09-28 Rekonstituerede surfaktanter med forbedrede egenskaber DK2078038T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (1)

Publication Number Publication Date
DK2078038T3 true DK2078038T3 (da) 2013-12-02

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07825212.9T DK2078038T3 (da) 2006-10-13 2007-09-28 Rekonstituerede surfaktanter med forbedrede egenskaber

Country Status (35)

Country Link
US (2) US8183210B2 (enExample)
EP (1) EP2078038B1 (enExample)
JP (2) JP5405307B2 (enExample)
KR (1) KR101328851B1 (enExample)
CN (2) CN103169947B (enExample)
AR (2) AR063263A1 (enExample)
AU (1) AU2007306075B2 (enExample)
BR (1) BRPI0715317B1 (enExample)
CA (1) CA2666344C (enExample)
CL (1) CL2007002931A1 (enExample)
CO (1) CO6400235A2 (enExample)
CY (1) CY1114716T1 (enExample)
DK (1) DK2078038T3 (enExample)
EA (1) EA015802B1 (enExample)
ES (1) ES2438727T3 (enExample)
GE (1) GEP20125531B (enExample)
HR (1) HRP20140052T1 (enExample)
IL (1) IL198075A (enExample)
JO (1) JO2963B1 (enExample)
MA (1) MA31062B1 (enExample)
ME (2) ME02326B (enExample)
MX (1) MX343064B (enExample)
MY (1) MY148127A (enExample)
NO (1) NO342038B1 (enExample)
NZ (1) NZ576189A (enExample)
PE (1) PE20081184A1 (enExample)
PL (1) PL2078038T3 (enExample)
PT (1) PT2078038E (enExample)
RS (1) RS53172B (enExample)
SI (1) SI2078038T1 (enExample)
TN (1) TN2009000099A1 (enExample)
TW (1) TWI388333B (enExample)
UA (1) UA94477C2 (enExample)
WO (1) WO2008044109A1 (enExample)
ZA (1) ZA200902481B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
US9815869B2 (en) 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
BR112015009486B1 (pt) 2012-11-21 2022-06-14 Chiesi Farmaceutici S.P.A Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
EP3393489B1 (en) * 2015-12-17 2021-09-01 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
CN109562139A (zh) 2016-08-24 2019-04-02 奇斯药制品公司 包含重构肺表面活性物质组合物的稳定药物制剂
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
EP4228691A4 (en) * 2020-10-16 2025-01-01 Biosuperior Technology, Inc. PULMONARY TREATMENT COMPOSITIONS
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706374B1 (en) * 1993-06-30 1997-12-10 Genentech, Inc. Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
WO2008044109A1 (en) 2008-04-17
HK1134497A1 (en) 2010-04-30
PT2078038E (pt) 2013-12-12
JO2963B1 (en) 2016-03-15
EA200900373A1 (ru) 2009-10-30
US20130079275A1 (en) 2013-03-28
MA31062B1 (fr) 2010-01-04
ES2438727T3 (es) 2014-01-20
TW200824705A (en) 2008-06-16
ME02326B (me) 2016-06-20
US8183210B2 (en) 2012-05-22
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
CY1114716T1 (el) 2016-10-05
CA2666344A1 (en) 2008-04-17
IL198075A0 (en) 2011-08-01
CN103169947A (zh) 2013-06-26
TN2009000099A1 (en) 2010-08-19
NZ576189A (en) 2011-09-30
JP5405307B2 (ja) 2014-02-05
CN101522711A (zh) 2009-09-02
AU2007306075A1 (en) 2008-04-17
AR063263A1 (es) 2009-01-14
PL2078038T3 (pl) 2014-05-30
KR20090083892A (ko) 2009-08-04
HRP20140052T1 (hr) 2014-02-28
MEP12109A (en) 2011-12-20
US9238058B2 (en) 2016-01-19
JP2013241449A (ja) 2013-12-05
AR113422A2 (es) 2020-04-29
EP2078038A1 (en) 2009-07-15
BRPI0715317A2 (pt) 2013-07-09
ZA200902481B (en) 2010-07-28
CA2666344C (en) 2017-04-18
CN101522711B (zh) 2013-11-13
EA015802B1 (ru) 2011-12-30
MY148127A (en) 2013-02-28
EP2078038B1 (en) 2013-11-20
JP2010505937A (ja) 2010-02-25
AU2007306075B2 (en) 2012-08-09
GEP20125531B (en) 2012-05-25
HK1185274A1 (en) 2014-02-14
TWI388333B (zh) 2013-03-11
SI2078038T1 (sl) 2014-02-28
RS53172B (sr) 2014-06-30
BRPI0715317B1 (pt) 2021-10-05
MX2009003638A (es) 2009-04-22
CL2007002931A1 (es) 2008-03-24
MX343064B (es) 2016-10-24
KR101328851B1 (ko) 2013-11-14
PE20081184A1 (es) 2008-09-26
NO20091441L (no) 2009-06-23
UA94477C2 (ru) 2011-05-10
US20100004173A1 (en) 2010-01-07
IL198075A (en) 2016-04-21
NO342038B1 (no) 2018-03-19

Similar Documents

Publication Publication Date Title
DK2078038T3 (da) Rekonstituerede surfaktanter med forbedrede egenskaber
EP2025266A4 (en) CUSHION DEVICE
DE602006021235D1 (de) Kristallglasgegenstand
EP2049173A4 (en) MICRO-NEEDLES REINFORCED BY ULTRASON
EP2087096A4 (en) MODIFIED CYANOBACTERIA
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
DK1849352T3 (da) Mejetærsker
BRPI0807137A2 (pt) Agentes antiparasitários
BRPI0914533A2 (pt) "métodos"
DK2051606T3 (da) Lænestol
EP2135606A4 (en) MEDIUM AGAINST TIREDNESS
SE0702067L (sv) Bestick
FI20070937L (fi) Perhekeinu
EP2054074A4 (en) MODIFIED ERYTHROPOIETIN
DK1927646T3 (da) Odoriseringsmiddel med forbedret stabilitet
ATE410929T1 (de) Verbessertes getränk
MA30860B1 (fr) Myrtillier denomme "c97-390"
DE502007000429D1 (de) Kinderhochstuhl
ATE488416T1 (de) Bob
DE602006016398D1 (de) Getränk
NO20091452L (no) Mottakerorientering
DE502007001011D1 (de) Kinderhochstuhl
DE602007013302D1 (de) Sitze
ES1063030Y (es) Somier mejorado
FI20065808A0 (fi) Lukitusjärjestely